Published in Am J Pathol on June 01, 2005
Multiple fusiform cerebral aneurysms and highly elevated serum interleukin-6 in cardiac myxoma. J Korean Neurosurg Soc (2009) 0.98
Multiple intracranial aneurysms followed left atrial myxoma: case report and literature review. J Thorac Dis (2013) 0.94
23-year experience on diagnosis and surgical treatment of benign and malignant cardiac tumors. Arch Med Sci (2013) 0.90
Circulating matrix metalloproteinases in infective endocarditis: a possible marker of the embolic risk. PLoS One (2011) 0.84
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients. J Transl Med (2015) 0.81
Propionyl-L-Carnitine Enhances Wound Healing and Counteracts Microvascular Endothelial Cell Dysfunction. PLoS One (2015) 0.80
Cytokine expression and ultrastructural alterations in fresh-frozen, freeze-dried and γ-irradiated human amniotic membranes. Cell Tissue Bank (2016) 0.77
Molecular basis of cardiac myxomas. Int J Mol Sci (2014) 0.75
High expression of cellular retinol binding protein-1 in lung adenocarcinoma is associated with poor prognosis. Genes Cancer (2015) 0.75
A case of primary subpleural pulmonary microcystic myxoma coincidentally occurred with pulmonary adenocarcinoma. J Pathol Transl Med (2015) 0.75
Clinical characteristics and long term post-operative outcome of cardiac myxoma. EXCLI J (2012) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Cardiac myxomas. N Engl J Med (1995) 14.96
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res (2003) 13.22
A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (1994) 9.31
Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res (2002) 6.37
Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore) (2001) 6.11
Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem (1995) 5.57
Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev (2000) 5.33
Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol (2003) 4.16
Proteoglycans: many forms and many functions. FASEB J (1992) 3.57
Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation (2001) 3.47
Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res (2002) 2.98
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell (2001) 2.97
Cardiac myxoma. A clinicopathologic study. Am J Clin Pathol (1993) 2.49
Matrix metalloproteinases and cardiovascular disease. Circ Res (1995) 2.27
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol (2003) 2.12
Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci (1999) 1.81
Echocardiographic and morphologic characteristics of left atrial myxoma and their relation to systemic embolism. Am J Cardiol (1999) 1.77
Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol (1996) 1.55
Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res (1998) 1.49
MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev (2003) 1.48
Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites. J Biol Chem (2000) 1.30
Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells. J Biol Chem (2001) 1.29
Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod (2002) 1.25
Cardiac myxomas. N Engl J Med (1996) 1.23
ATP modulates load-inducible IL-1beta, COX 2, and MMP-3 gene expression in human tendon cells. J Cell Biochem (2003) 1.17
Histogenesis of cardiac myxomas. An immunohistochemical study of 19 cases, including one with glandular structures, and review of the literature. Arch Pathol Lab Med (1989) 1.16
Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. J Pathol (2001) 1.16
Regulation of membrane type-matrix metalloproteinases. Semin Cancer Biol (2002) 1.15
Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2003) 1.12
MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res Treat (2002) 1.10
Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas. Br J Cancer (2001) 1.03
Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril (2002) 0.98
Regulation of heart morphology: current molecular and cellular perspectives on the coordinated emergence of cardiac form and function. Birth Defects Res C Embryo Today (2003) 0.95
Overexpression of matrix metalloproteinase-9 promotes intravascular thrombus formation in porcine coronary arteries in vivo. Cardiovasc Res (2003) 0.95
Role of the matrixin MMP-2 in multicellular organization of adipocytes cultured in basement membrane components. Am J Physiol (1997) 0.93
Molecular mechanism of the induction of metalloproteinases 1 and 3 in human fibroblasts by basic calcium phosphate crystals. Role of calcium-dependent protein kinase C alpha. J Biol Chem (2002) 0.93
Matrix metalloproteinases and cancer. Anticancer Res (2002) 0.91
Correlation of interleukin-6 gene expression to immunologic features in patients with cardiac myxomas. J Interferon Cytokine Res (1996) 0.90
Superficial pseudoaneurysms: clinicopathologic aspects and involvement of extracellular matrix proteoglycans. Mod Pathol (2004) 0.87
Cleavage of native cartilage aggrecan by neutrophil collagenase (MMP-8) is distinct from endogenous cleavage by aggrecanase. J Biol Chem (1997) 0.86
Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells. J Cell Physiol (2002) 0.86
Phenotypic heterogeneity influences apoptotic susceptibility to retinoic acid and cis-platinum of rat arterial smooth muscle cells in vitro: Implications for the evolution of experimental intimal thickening. Arterioscler Thromb Vasc Biol (2001) 0.86
Cardiac myxoma: histochemical and ultrastructural localization of glycosaminoglycans and proteoglycans. Ultrastruct Pathol (1984) 0.79
Disaccharide analysis of glycosaminoglycans synthesized by cardiac myxoma cells in tumor tissues and in cell culture. Life Sci (2003) 0.77
Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial. J Natl Cancer Inst (2005) 3.64
Coronary flow characteristics after a Bentall procedure with or without sinuses of Valsalva. Eur J Cardiothorac Surg (2004) 2.09
Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation (2002) 2.02
Age-related increase of stem marker expression influences vascular smooth muscle cell properties. Atherosclerosis (2012) 1.77
Cardiac sarcomas: an update. J Thorac Oncol (2010) 1.71
Long-term outcome of coronary artery bypass grafting in patients with left ventricular dysfunction. Ann Thorac Surg (2009) 1.58
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS One (2008) 1.56
Simultaneous hybrid revascularization by carotid stenting and coronary artery bypass grafting: the SHARP study. JACC Cardiovasc Interv (2009) 1.51
Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol (2005) 1.51
Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene (2004) 1.50
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). J Am Coll Cardiol (2002) 1.46
Aortic root surgery in Marfan syndrome: Bentall procedure with the composite mechanical valved conduit versus aortic valve reimplantation with Valsalva graft. J Cardiovasc Med (Hagerstown) (2010) 1.45
Analysis of valve motion after the reimplantation type of valve-sparing procedure (David I) with a new aortic root conduit. Ann Thorac Surg (2002) 1.42
Midterm results of different surgical techniques to replace dilated ascending aorta associated with bicuspid aortic valve disease. Ann Thorac Surg (2013) 1.39
Performance of a novel sternal synthesis device after median and faulty sternotomy: mechanical test and early clinical experience. Ann Thorac Surg (2008) 1.39
Benefit of partial right-bilateral internal thoracic artery harvesting in patients at risk of sternal wound complications. Ann Thorac Surg (2006) 1.38
Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Methods (2009) 1.29
Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: application to MALDI-TOF imaging MS investigations. Proteomics (2008) 1.27
Extracellular proteases in atherosclerosis and restenosis. Arterioscler Thromb Vasc Biol (2005) 1.27
Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology (2005) 1.22
Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis. Atherosclerosis (2006) 1.17
Probing new physics via the B(s)0→μ(+)μ- effective lifetime. Phys Rev Lett (2012) 1.15
Abdominal Aortic dissections: anatomic and clinical features and therapeutic options. Tex Heart Inst J (2005) 1.10
Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats. PLoS One (2008) 1.08
Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. Am J Pathol (2006) 1.07
Pivotal points to prevent iatrogenic infections triggered by hysteroscopy. Aust N Z J Obstet Gynaecol (2013) 1.07
Microcalcifications in breast cancer: an active phenomenon mediated by epithelial cells with mesenchymal characteristics. BMC Cancer (2014) 1.06
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. Am J Pathol (2006) 1.06
One-year appraisal of a new aortic root conduit with sinuses of Valsalva. J Thorac Cardiovasc Surg (2002) 1.06
miR-24 triggers epidermal differentiation by controlling actin adhesion and cell migration. J Cell Biol (2012) 1.04
Alpha-actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study. J Pathol (2003) 1.03
Aortic root enlargement for aortic valve replacement in an achondroplastic dwarf. Tex Heart Inst J (2005) 1.02
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection. Gastroenterology (2004) 1.02
Survival and durability of mitral valve repair surgery for degenerative mitral valve disease. J Card Surg (2011) 1.02
Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events. J Am Coll Cardiol (2006) 1.02
The effect of bilateral internal thoracic artery harvesting on superficial and deep sternal infection: The role of skeletonization. J Thorac Cardiovasc Surg (2005) 1.01
Propionyl-L-carnitine improves postischemic blood flow recovery and arteriogenetic revascularization and reduces endothelial NADPH-oxidase 4-mediated superoxide production. Arterioscler Thromb Vasc Biol (2010) 0.99
Permanent pacemaker implantation after isolated aortic valve replacement: incidence, risk factors and surgical technical aspects. J Cardiovasc Med (Hagerstown) (2010) 0.99
Carnitine palmitoyltransferase I in human carcinomas: a novel role in histone deacetylation? Cancer Biol Ther (2007) 0.98
Superficial wound dehiscence after median sternotomy: surgical treatment versus secondary wound healing. Ann Thorac Surg (2004) 0.98
Postoperative aortic fistulas into the airways: etiology, pathogenesis, presentation, diagnosis, and management. Ann Thorac Surg (2003) 0.97
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med (2008) 0.95
Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist. Mol Cancer Ther (2005) 0.93
Reimplantation valve-sparing aortic root replacement in Marfan syndrome using the Valsalva conduit: an intercontinental multicenter study. Ann Thorac Surg (2007) 0.92
Undifferentiated sarcoma of the heart: a rare clinicopathologic presentation. J Thorac Cardiovasc Surg (2002) 0.92
Modulation of clusterin isoforms is associated with all-trans retinoic acid-induced proliferative arrest and apoptosis of intimal smooth muscle cells. Arterioscler Thromb Vasc Biol (2004) 0.91
Use of the Valsalva graft and long-term follow-up. J Thorac Cardiovasc Surg (2010) 0.91
Difficulty diagnosing chronic cryptococcal meningitis in idiopathic CD4+ lymphocytopenia. Neurol Sci (2011) 0.89
In vitro evaluation of aortic valve prosthesis in a novel valved conduit with pseudosinuses of Valsalva. J Thorac Cardiovasc Surg (2005) 0.89
High-resolution multicontrast-weighted MR imaging from human carotid endarterectomy specimens to assess carotid plaque components. Eur Radiol (2008) 0.88
Role of ageing and coronary atherosclerosis in the development of cardiac fibrosis in the rabbit. Cardiovasc Res (2004) 0.87
Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome. Acta Derm Venereol (2011) 0.87
Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications. Mod Pathol (2006) 0.86
Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg (2002) 0.86
Modified radical hysterectomy versus extrafascial hysterectomy in the treatment of stage I endometrial cancer: results from the ILIADE randomized study. Ann Surg Oncol (2009) 0.85
Conversion to sinus rhythm by ablation improves quality of life in patients submitted to mitral valve surgery. Ann Thorac Surg (2006) 0.85
Early and long-term results of pectoralis muscle flap reconstruction versus sternal rewiring following failed sternal closure. Eur J Cardiothorac Surg (2013) 0.84
Propionyl-L-carnitine reduces proliferation and potentiates Bax-related apoptosis of aortic intimal smooth muscle cells by modulating nuclear factor-kappaB activity. J Biol Chem (2006) 0.84
[Unstable carotid plaque: biochemical and cellular marker of vulnerability]. Ital Heart J Suppl (2003) 0.83
Complication of nasal piercing by Staphylococcus aureus endocarditis: a case report and a review of literature. Cases J (2010) 0.83
Prediction of cardiovascular events by inflammatory markers in patients undergoing carotid stenting. Mayo Clin Proc (2012) 0.83
Flt-1 expression influences apoptotic susceptibility of vascular smooth muscle cells through the NF-kappaB/IAP-1 pathway. Cardiovasc Res (2010) 0.83
Sequential hybrid carotid and coronary artery revascularization: immediate and mid-term results. Ann Thorac Surg (2007) 0.82
Alpha actin isoforms expression in human and rat adult cardiac conduction system. Differentiation (2009) 0.82
Total laparoscopic radical parametrectomy, partial colpectomy, and pelvic lymphadenectomy in patients with occult cervical cancer. Int J Gynaecol Obstet (2009) 0.82
Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. Eur Heart J (2005) 0.81
Phenotypic heterogeneity influences the behavior of rat aortic smooth muscle cells in collagen lattice. Exp Cell Res (2005) 0.81
Stem cell marker expression and proliferation and apoptosis of vascular smooth muscle cells. Cell Cycle (2008) 0.80
High levels of cellular retinol binding protein-1 expression in leiomyosarcoma: possible implications for diagnostic evaluation. Virchows Arch (2002) 0.80
Antioxidant treatment prevents serum deprivation- and TNF-α-induced endothelial dysfunction through the inhibition of NADPH oxidase 4 and the restoration of β-oxidation. J Vasc Res (2014) 0.80
Stool test for colorectal cancer screening: what is going on? Surg Oncol (2007) 0.80
Propionyl-L-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells. Atherosclerosis (2002) 0.79
Transglutaminase 2 as a biomarker of osteoarthritis: an update. Amino Acids (2011) 0.79
Five-year clinical outcome and patency rate of device-dependent venous grafts after clampless OPCAB with PAS-port automated proximal anastomosis: the PAPA Study. J Card Surg (2014) 0.79
Effect of atorvastatin (80 mg) initiated at the time of coronary artery stent implantation on C-reactive protein and six-month clinical events. Am J Cardiol (2002) 0.79
Relation between animal-type melanoma and reduced nuclear expression of glutathione S-transferase pi. Arch Dermatol (2009) 0.78
Cardiac surgery with extracorporeal circulation and concomitant malignancy: early and long-term results. J Cardiovasc Med (Hagerstown) (2016) 0.78
Effects of ascending aorta replacement on aortic root dilatation. Eur J Cardiothorac Surg (2005) 0.78